Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing announced
– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders
Share this article NT-17 is one of several US government-funded acute radiation syndrome (ARS) countermeasure projects. Credit: graja/Shutterstock.com The US Food and Drug Administration (FDA)
A team led by researchers at Weill Cornell Medicine has used an AI-based approach to uncover underlying patterns among the conditions in which people are
Cambridge scientists have shown that placing physical constraints on an artificially-intelligent system – in much the same way that the human brain has to develop
Related Articles After a Bay State cannabis worker suffered an asthma attack and died, the state Department of Public Health is pushing the local marijuana
Karu F. Daniels | New York Daily News Pot proponent Snoop Dogg is seemingly dropping his obsessive weed habit. The 16-time Grammy-nominated hip-hop star, whose
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic received approval from the
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Macroeconomic pressures continued to weigh on medical device companies for another quarter, but there were also signs of hope for global supply chains and inflation.